Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0M0SS
|
||||
Former ID |
DNC007102
|
||||
Drug Name |
FARGLITAZAR
|
||||
Drug Type |
Small molecular drug
|
||||
Structure |
Download2D MOL |
||||
Formula |
C34H30N2O5
|
||||
InChI |
InChI=1S/C34H30N2O5/c1-23-29(36-33(41-23)26-12-6-3-7-13-26)20-21-40-27-18-16-24(17-19-27)22-31(34(38)39)35-30-15-9-8-14-28(30)32(37)25-10-4-2-5-11-25/h2-19,31,35H,20-22H2,1H3,(H,38,39)/t31-/m0/s1
|
||||
InChIKey |
ZZCHHVUQYRMYLW-HKBQPEDESA-N
|
||||
CAS Number |
CAS 196808-45-4
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
583730, 841881, 7885389, 10257297, 11364759, 11367321, 11369883, 11375483, 11378048, 12015156, 14788109, 14788110, 26705557, 46243411, 46391907, 47206079, 47736584, 50068576, 53387450, 53789440, 57351836, 103324541, 103984527, 113467854, 124954245, 129975797, 134344307, 135126503, 135650251, 140275633, 144210538, 179150128, 198947133, 223908695, 226815712
|
||||
Target and Pathway | |||||
Target(s) | Peroxisome proliferator activated receptor gamma | Target Info | Modulator | ||
PANTHER Pathway | CCKR signaling map ST | ||||
WikiPathways | Wnt Signaling Pathway Netpath | ||||
Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
Differentiation of white and brown adipocyte | |||||
Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) | |||||
Transcriptional Regulation of White Adipocyte Differentiation | |||||
Adipogenesis | |||||
SREBP signalling | |||||
Nuclear Receptors | |||||
References | |||||
Ref 539738 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2672). | ||||
Ref 549914 | Clinical pipeline report, company report or official report of MacroGenics. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.